Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T09544 | Target Info | |||
Target Name | Galectin-1 (LGALS1) | ||||
Synonyms | SLac lectin 1; S-Lac lectin 1; Putative MAPKactivating protein PM12; Putative MAPK-activating protein PM12; Lectin galactosidebinding soluble 1; Lectin galactoside-binding soluble 1; Lactosebinding lectin 1; Lactose-binding lectin 1; HPL; HLBP14; HBL; Galaptin; Gal1; Gal-1; Betagalactosidebinding lectin L14I; Beta-galactoside-binding lectin L-14-I; 14 kDa lectin; 14 kDa lamininbinding protein; 14 kDa laminin-binding protein | ||||
Target Type | Patented-recorded Target | ||||
Gene Name | LGALS1 | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | S,S-(2-Hydroxyethyl)Thiocysteine | Ligand Info | |||
Canonical SMILES | C(CSSCC(C(=O)O)N)O | ||||
InChI | 1S/C5H11NO3S2/c6-4(5(8)9)3-11-10-2-1-7/h4,7H,1-3,6H2,(H,8,9)/t4-/m0/s1 | ||||
InChIKey | YPUBRSXDQSFQBA-BYPYZUCNSA-N | ||||
PubChem Compound ID | 170018 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 3T2T Crystal structure of human galectin-1 in complex with methyl 2-O-acetyl-3-O-toluoyl-beta-D-talopyranoside | ||||||
Method | X-ray diffraction | Resolution | 1.90 Å | Mutation | No | [1] |
PDB Sequence |
ACGLVASNLN
10 LKPGELRVRG21 EVAPDAKSFV31 LNLGKDSNNL41 CLHFNPRFNA51 HGDANTIVCN 61 SKDGGAWGTE71 QREAVFPFQP81 GSVAEVITFD92 QANLTVKLPD102 GYEFKFPNRL 112 NLEAINYMAA122 DGDFKIKVAF133 D
|
|||||
|
LEU11
4.121
GLY14
3.985
GLU15
1.323
LEU17
1.332
ARG18
3.633
VAL19
3.508
ARG20
2.903
GLU86
3.062
VAL87
1.336
ILE89
1.329
THR90
3.929
THR97
3.823
|
|||||
PDB ID: 4Q2F Galectin-1 in Complex with Ligand AN020 | ||||||
Method | X-ray diffraction | Resolution | 1.40 Å | Mutation | No | [2] |
PDB Sequence |
CGLVASNLNL
11 KPGELRVRGE22 VAPDAKSFVL32 NLGKDSNNLC42 LHFNPRFNAH52 GDANTIVCNS 62 KDGGAWGTEQ72 REAVFPFQPG82 SVAEVITFDQ93 ANLTVKLPDG103 YEFKFPNRLN 113 LEAINYMAAD123 GDFKIKVAFD134
|
|||||
|
LEU11
3.229
GLY14
3.995
GLU15
1.336
LEU17
1.329
ARG18
2.358
VAL19
2.553
ARG20
1.970
GLU86
2.419
VAL87
1.331
ILE89
1.325
THR90
1.988
THR97
3.696
|
|||||
PDB ID: 4Q1P Galectin-1 in Complex with Ligand NB169 | ||||||
Method | X-ray diffraction | Resolution | 1.46 Å | Mutation | No | [3] |
PDB Sequence |
CGLVASNLNL
11 KPGELRVRGE22 VAPDAKSFVL32 NLGKDSNNLC42 LHFNPRFNAH52 GDANTIVCNS 62 KDGGAWGTEQ72 REAVFPFQPG82 SVAEVITFDQ93 ANLTVKLPDG103 YEFKFPNRLN 113 LEAINYMAAD123 GDFKIKVAFD134
|
|||||
|
LEU11
3.240
GLY14
4.024
GLU15
1.331
LEU17
1.327
ARG18
2.585
VAL19
2.631
ARG20
1.996
GLU86
2.528
VAL87
1.324
ILE89
1.327
THR90
2.137
|
|||||
PDB ID: 4Q1R Galectin-1 in Complex with Ligand AN027 | ||||||
Method | X-ray diffraction | Resolution | 1.47 Å | Mutation | No | [4] |
PDB Sequence |
CGLVASNLNL
11 KPGELRVRGE22 VAPDAKSFVL32 NLGKDSNNLC42 LHFNPRFNAH52 GDANTIVCNS 62 KDGGAWGTEQ72 REAVFPFQPG82 SVAEVITFDQ93 ANLTVKLPDG103 YEFKFPNRLN 113 LEAINYMAAD123 GDFKIKVAFD134
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .CME or .CME2 or .CME3 or :3CME;style chemicals stick;color identity;select .A:11 or .A:14 or .A:15 or .A:17 or .A:18 or .A:19 or .A:20 or .A:86 or .A:87 or .A:89 or .A:90 or .A:97 or .A:98 or .A:99 or .A:100 or .A:101 or .A:102 or .A:128 or .A:129 or .A:131 or .A:132 or .A:133 or .A:134; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
LEU11
3.273
GLY14
3.922
GLU15
1.331
LEU17
1.330
ARG18
2.574
VAL19
2.618
ARG20
2.053
GLU86
2.556
VAL87
1.329
ILE89
1.326
THR90
2.098
THR97
3.711
|
|||||
PDB ID: 6F83 Crystal Structure of Human Galectin-1 in Complex With Thienyl-1,2, 3-triazolyl Thiodigalactoside Inhibitor | ||||||
Method | X-ray diffraction | Resolution | 2.20 Å | Mutation | No | [5] |
PDB Sequence |
ACGLVASNLN
10 LKPGELRVRG21 EVAPDAKSFV31 LNLGKDSNNL41 LHFNPRFNAH52 GDANTIVNSK 63 DGGAWGTEQR73 EAVFPFQPGS83 VAEVITFDQA94 NLTVKLPDGY104 EFKFPNRLNL 114 EAINYMAADG124 DFKIKVAFD
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .CME or .CME2 or .CME3 or :3CME;style chemicals stick;color identity;select .A:11 or .A:14 or .A:15 or .A:17 or .A:18 or .A:19 or .A:20 or .A:34 or .A:35 or .A:40 or .A:41 or .A:43 or .A:44 or .A:45 or .A:58 or .A:59 or .A:61 or .A:62 or .A:70 or .A:71 or .A:72 or .A:73 or .A:74 or .A:86 or .A:87 or .A:89 or .A:90 or .A:91 or .A:96 or .A:97 or .A:98 or .A:99 or .A:100 or .A:101 or .A:106 or .A:107 or .A:108 or .A:109 or .A:110 or .A:112 or .A:113 or .A:114 or .A:116 or .A:117 or .A:128 or .A:129 or .A:131 or .A:132 or .A:133 or .A:134; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
LEU11
4.406
GLY14
4.076
GLU15
1.330
LEU17
1.322
ARG18
3.365
VAL19
3.534
ARG20
2.846
LEU34
2.778
GLY35
3.873
ASN40
4.140
LEU41
1.325
LEU43
1.327
HIS44
3.136
PHE45
3.920
ILE58
3.892
VAL59
1.332
ASN61
1.319
SER62
4.383
THR70
4.441
GLU71
3.563
GLN72
2.852
ARG73
4.274
GLU74
2.757
GLU86
3.498
VAL87
1.329
ILE89
1.332
THR90
3.313
PHE91
3.786
LEU96
3.439
THR97
3.743
VAL98
3.334
LYS99
2.750
LEU100
2.888
PRO101
3.785
PHE106
3.100
LYS107
3.551
PHE108
3.705
PRO109
4.731
ASN110
2.451
LEU112
3.721
ASN113
3.397
LEU114
3.195
ALA116
4.544
ILE117
3.485
ILE128
3.508
LYS129
1.333
VAL131
1.327
ALA132
3.686
PHE133
3.511
ASP134
2.976
|
|||||
PDB ID: 5MWX Galectin-1 in Complex with Ligand JB60 | ||||||
Method | X-ray diffraction | Resolution | 1.29 Å | Mutation | No | [6] |
PDB Sequence |
CGLVASNLNL
11 KPGELRVRGE22 VAPDAKSFVL32 NLGKDSNNLC42 LHFNPRFNAH52 GDANTIVCNS 62 KDGGAWGTEQ72 REAVFPFQPG82 SVAEVITFDQ93 ANLTVKLPDG103 YEFKFPNRLN 113 LEAINYMAAD123 GDFKIKVAFD134
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .CME or .CME2 or .CME3 or :3CME;style chemicals stick;color identity;select .A:11 or .A:14 or .A:15 or .A:17 or .A:18 or .A:19 or .A:20 or .A:21 or .A:86 or .A:87 or .A:89 or .A:90 or .A:97 or .A:98 or .A:99 or .A:100 or .A:101 or .A:102 or .A:128 or .A:129 or .A:131 or .A:132 or .A:133 or .A:134; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
LEU11
3.140
GLY14
3.996
GLU15
1.334
LEU17
1.332
ARG18
2.465
VAL19
2.665
ARG20
2.022
GLY21
4.423
GLU86
2.407
VAL87
1.318
ILE89
1.316
THR90
2.176
|
|||||
PDB ID: 7NML Galectin-1 in complex with 4-Amino-6-chloro-1,3-benzenedisulfonamide | ||||||
Method | X-ray diffraction | Resolution | 1.43 Å | Mutation | No | [7] |
PDB Sequence |
CGLVASNLNL
11 KPGELRVRGE22 VAPDAKSFVL32 NLGKDSNNLC42 LHFNPRFNAH52 GDANTIVCNS 62 KDGGAWGTEQ72 REAVFPFQPG82 SVAEVITFDQ93 ANLTVKLPDG103 YEFKFPNRLN 113 LEAINYMAAD123 GDFKIKVAFD134
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .CME or .CME2 or .CME3 or :3CME;style chemicals stick;color identity;select .A:11 or .A:14 or .A:15 or .A:17 or .A:18 or .A:19 or .A:20 or .A:21 or .A:86 or .A:87 or .A:89 or .A:90 or .A:97 or .A:98 or .A:99 or .A:100 or .A:101 or .A:102 or .A:103 or .A:128 or .A:129 or .A:131 or .A:132 or .A:133 or .A:134; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
LEU11
3.167
GLY14
3.975
GLU15
1.328
LEU17
1.321
ARG18
2.082
VAL19
2.655
ARG20
2.037
GLY21
4.957
GLU86
2.187
VAL87
1.333
ILE89
1.333
THR90
2.247
THR97
3.578
|
|||||
PDB ID: 5MWT Galectin-1 in Complex with Ligand JB97 | ||||||
Method | X-ray diffraction | Resolution | 1.71 Å | Mutation | No | [8] |
PDB Sequence |
CGLVASNLNL
11 KPGELRVRGE22 VAPDAKSFVL32 NLGKDSNNLC42 LHFNPRFNAH52 GDANTIVCNS 62 KDGGAWGTEQ72 REAVFPFQPG82 SVAEVITFDQ93 ANLTVKLPDG103 YEFKFPNRLN 113 LEAINYMAAD123 GDFKIKVAFD134
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .CME or .CME2 or .CME3 or :3CME;style chemicals stick;color identity;select .A:11 or .A:14 or .A:15 or .A:17 or .A:18 or .A:19 or .A:20 or .A:21 or .A:86 or .A:87 or .A:89 or .A:90 or .A:97 or .A:98 or .A:99 or .A:100 or .A:101 or .A:102 or .A:128 or .A:129 or .A:131 or .A:132 or .A:133 or .A:134; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
LEU11
3.362
GLY14
3.971
GLU15
1.329
LEU17
1.330
ARG18
2.468
VAL19
2.609
ARG20
2.064
GLY21
4.290
GLU86
2.414
VAL87
1.331
ILE89
1.331
THR90
2.852
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Taloside inhibitors of galectin-1 and galectin-3. Chem Biol Drug Des. 2012 Mar;79(3):339-46. | ||||
REF 2 | Galectin-1 in Complex with Ligand AN020 | ||||
REF 3 | Galectin-1 in Complex with Ligand NB169 | ||||
REF 4 | Galectin-1 in Complex with Ligand AN027 | ||||
REF 5 | Aromatic heterocycle galectin-1 interactions for selective single-digit nM affinity ligands | ||||
REF 6 | Galectin-1 in Complex with Ligand JB60 | ||||
REF 7 | Galectin-1 in complex with 4-Amino-6-chloro-1,3-benzenedisulfonamide | ||||
REF 8 | Structural insights into the redesign of a sucrose phosphorylase by induced loop repositioning |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.